
Heidi Ko/LinkedIn
May 21, 2025, 12:38
Heidi Ko: The Importance of Biomarker Testing HER2 in Cancer Care
Heidi Ko, Medical Director of Medical Affairs at Labcorp Drug Development, shared a post on LinkedIn:
“Feeling incredibly grateful for this opportunity with Outcomes4Me to talk about the importance of biomarker testing HER2 in cancer care to our listeners today!
Thank you to my amazing team Labcorp for making this happen!”
More posts featuring Heidi Ko.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 21, 2025, 12:38
May 21, 2025, 12:32
May 21, 2025, 12:14
May 21, 2025, 12:07
May 21, 2025, 11:32
May 21, 2025, 09:58